RT @doctorRBC: JAKinib safety takeaways - avoid in older population > 65 yo, malignancy, CV risk, VTE risk - appropri
Tweet Content
JAKinib safety takeaways
- avoid in older population > 65 yo, malignancy, CV risk, VTE risk
- appropriate in younger pts without VTE/CVD risk factors
#RNL2023 @RheumNow https://t.co/5i1bRqqr7g
Show on Archive Page
On
Display in Search Results
On
PDQ
Off